Genitourinary Pathology is the subspecialty of Pathology that evaluates diseases of the urinary system and male reproductive system. We offer diagnostic expertise spanning a range of diseases involving the kidney, bladder, prostate and testis, among others.


Wen-Chi Foo, MD, is an Associate Professor of Pathology specializing in Genitourinary surgical pathology and cytopathology. Foo completed her pathology residency at Duke Hospital and Cytopathology fellowship at Brigham and Women’s Hospital before returning to join the Duke faculty in 2013. Her research interests broadly center on identifying molecular markers with high diagnostic and prognostic utility, as well as investigating the application of new technology to pathology specimens. This includes investigating how current knowledge of molecular mechanisms of oncogenesis and tumor progression can be exploited to improve diagnosis in fine needle aspiration biopsy, as well as application of deep learning to the diagnosis of prostate cancer in surgical pathology specimens. 

Jiaoti Huang, MD, PhD, is a physician-scientist with clinical expertise in the pathologic diagnosis of genitourinary tumors including tumors of the prostate, bladder, kidney and testis. Another area of interest is gynecologic tumors. His research laboratory studies prostate cancer, focusing on molecular mechanisms of carcinogenesis and tumor progression, as well as biomarkers, imaging and novel therapeutic strategies. In addition to patient care and research, He is also passionate about education and has trained numerous residents, fellows, graduate students and postdocs.

Avani Pendse, MD, PhDis an Assistant Professor of Pathology specializing in gastro-intestinal and genito-urinary surgical pathology and cytopathology. Pendse completed her residency, cytopathology fellowship and surgical pathology instructorship at the University of North Carolina at Chapel Hill and came to Duke in 2017. Her research pursuits include investigation to improve the morphologic and proteomic based understanding of gastro-intestinal disease. In her role as the Associate Director of Proteomics of the Duke BioRepository and Precision Pathology Center, she is currently focused on developing multiplex immunohistochemistry panels to study immunologic and oncologic diseases.